Mir155 as the integration site to overcome acute graft versus host disease of gene-modified immune effector cells
US-2025032545-A1 · Jan 30, 2025 · US
This patent family groups 1 related publication across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 94372943 |
| Family type | — |
| Earliest priority | Jul 26, 2023 |
| First filing country | US |
| Member publications | 1 |
| Countries | US |
| Representative publication | US2025032545A1 — Mir155 as the integration site to overcome acute graft versus host disease of gene-modified immune effector cells |
Best representative member for this family based on priority and filing country.
US2025032545A1 — Mir155 as the integration site to overcome acute graft versus host disease of gene-modified immune effector cells (published Jan 30, 2025)
Related publications in this family.